Buyer landscape
Likely buyers · Biotech in Norway.
Prepared 2026-08-28 with GP Intel · deterministic scoring, published weights: gp-intel.com/methodology/league-tables
The list: 25 Tier 1 · 0 Tier 2 of 120 matched buyers, including 21 geographic expansion candidates without a local platform yet. A first round of the Tier 1 names plus the expansion buyers covers the demonstrated demand.
Financial buyers · 24
Tier 1 · Very High · score 70+
1. Bpifrance Investissement SponsorVery High81
10 platform investments in Healthcare · 35 deals 2024–26
AUM €57.3B · Bpifrance Amorçage Industriel · 2023 vintage · deploying · check €1-8M
Accelerating: 30 deals in the last 2 years vs 4.5/yr before.
Backed Adcendo, 2026 · Biotech, Denmark
2. Novo Holdings SponsorVery High80
114 platform investments in Healthcare · 1 in Norway · 43 deals 2024–26
AUM €93.0B · Novo Holdings Bioindustrial Investments · 1999 vintage · no newer fund
142 platform investments since the 1999 vintage · largely deployed vs its usual 24 per fund.
Backed cAMPfield, 2026 · Biotech, US
3. Axcel SponsorVery High80
9 platform investments in Healthcare · 6 in Norway · 14 deals 2024–26
Axcel VII · 2023 vintage · deploying · check €26-194M
15 platform investments since the 2023 vintage · largely deployed vs its usual 9 per fund.
Backed Sangro, 2026 · Healthcare, Germany
4. ArchiMed SponsorVery High79
56 platform investments in Healthcare · 18 deals 2024–26
AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M
18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.
Backed ExcellGene, 2025 · Biotech, Switzerland
5. Archimedes Partners SponsorVery High79
53 platform investments in Healthcare · 21 deals 2024–26
AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M
18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.
Backed ExcellGene, 2025 · Biotech, Switzerland
6. ARCHIMED and Institut Mérieux SponsorVery High79
54 platform investments in Healthcare · 19 deals 2024–26
AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M
18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.
Backed ExcellGene, 2025 · Biotech, Switzerland
7. ArchiMed and Tethys Invest SponsorVery High79
54 platform investments in Healthcare · 18 deals 2024–26
AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M
18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.
Backed ExcellGene, 2025 · Biotech, Switzerland
8. IK Partners SponsorVery High78
34 platform investments in Healthcare · 13 in Norway · 52 deals 2024–26
AUM €13.8B · IK Partnership Fund III · 2025 vintage · deploying · check €10-75M
18 platform investments since the 2025 vintage · largely deployed vs its usual 13 per fund.
Bought Biobank from Bpifrance Investissement, 2024 · Biotech, France
9. Lauxera Capital Partners SponsorVery High78
16 platform investments in Healthcare · 6 deals 2024–26
AUM €780M · Lauxera Growth II · 2025 vintage · deploying · check €10-78M
3 platform investments since the 2025 vintage · early in deployment vs its usual 8 per fund.
Backed GenePlanet, 2026 · Biotech, Slovenia
10. Bridgepoint SponsorVery High77
34 platform investments in Healthcare · 3 in Norway · 43 deals 2024–26
AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M
4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.
Bought {my}dentist (formerly IDH) from Palamon Capital Partners, 2025 · Healthcare, UK
11. Bridgepoint Development Capital SponsorVery High77
31 platform investments in Healthcare · 3 in Norway · 36 deals 2024–26
AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M
4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.
Backed {my}dentist (formerly IDH), 2025 · Healthcare, UK
12. Bridgepoint (52.5% majority stake) SponsorVery High77
30 platform investments in Healthcare · 3 in Norway · 36 deals 2024–26
AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M
4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.
Backed {my}dentist (formerly IDH), 2025 · Healthcare, UK
13. Bridgepoint BE VII + General Atlantic SponsorVery High77
30 platform investments in Healthcare · 3 in Norway · 37 deals 2024–26
AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M
4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.
Backed {my}dentist (formerly IDH), 2025 · Healthcare, UK
14. Bridgepoint Capital SponsorVery High77
31 platform investments in Healthcare · 3 in Norway · 36 deals 2024–26
AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M
4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.
Backed {my}dentist (formerly IDH), 2025 · Healthcare, UK
15. Bridgepoint Capital Developpement SponsorVery High77
30 platform investments in Healthcare · 3 in Norway · 36 deals 2024–26
AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M
4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.
Backed {my}dentist (formerly IDH), 2025 · Healthcare, UK
16. Bridgepoint Development Capital (with Paluel-Marmont Capital & LT Capital) SponsorVery High77
30 platform investments in Healthcare · 3 in Norway · 36 deals 2024–26
AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M
4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.
Backed {my}dentist (formerly IDH), 2025 · Healthcare, UK
17. Ring Capital SponsorVery High77
10 platform investments in Healthcare · 1 in Norway · 32 deals 2024–26
AUM €470M · Ring Altitude II · 2025 vintage · deploying · check €4-33M
17 platform investments since the 2025 vintage · largely deployed vs its usual 13 per fund.
Backed Exapto, 2024 · Biotech, France
18. Merieux Equity Partners / Vitruvian Partners SponsorVery High77
57 platform investments in Healthcare · 6 deals 2024–26
AUM €1.6B · Mérieux Participations 5 · 2026 vintage · deploying · check €7-50M
2 platform investments since the 2026 vintage · early in deployment vs its usual 8 per fund.
Backed Ona Therapeutics, 2026 · Biotech, Spain
20. Inflexion SponsorVery High76
10 platform investments in Healthcare · 27 deals 2024–26
AUM €11.0B · Inflexion Buyout Fund VII · 2026 vintage · deploying · check €90-675M
4 platform investments since the 2026 vintage · mid-deployment vs its usual 6 per fund.
Bought Primed from Paragon Partners, 2026 · MedTech, Germany
21. NORD Holding SponsorVery High76
15 platform investments in Healthcare · 15 deals 2024–26
AUM €5.0B · NORD Holding all inclusive Fitness Continuation Fund · 2026 vintage · deploying
Accelerating: 13 deals in the last 2 years vs 2.5/yr before.
Bought Hallmarq Veterinary Imaging from August Equity, 2026 · MedTech, UK
22. IK Partners (IK Small Cap III) SponsorVery High75
29 platform investments in Healthcare · 13 in Norway · 39 deals 2024–26
AUM €13.8B · IK Partnership Fund III · 2025 vintage · deploying · check €10-75M
18 platform investments since the 2025 vintage · largely deployed vs its usual 13 per fund.
Backed Sterimed, 2025 · MedTech, France
23. IK Partners / GIC / Keensight / Parquest / management SponsorVery High75
28 platform investments in Healthcare · 13 in Norway · 38 deals 2024–26
AUM €13.8B · IK Partnership Fund III · 2025 vintage · deploying · check €10-75M
18 platform investments since the 2025 vintage · largely deployed vs its usual 13 per fund.
Backed Sterimed, 2025 · MedTech, France
24. NORD Holding / Pinova Capital SponsorVery High75
12 platform investments in Healthcare · 12 deals 2024–26
AUM €5.0B · NORD Holding all inclusive Fitness Continuation Fund · 2026 vintage · deploying
Accelerating: 10 deals in the last 2 years vs 2.5/yr before.
Backed Hallmarq Veterinary Imaging, 2026 · MedTech, UK
25. Audacia SponsorVery High74
9 platform investments in Healthcare · 27 deals 2024–26
AUM €2.8B · Audacia Capital Développement IV · 2023 vintage · deploying · check €4-30M
45 platform investments since the 2023 vintage · largely deployed vs its usual 12 per fund.
Backed Biomemory, 2025 · Biotech, France
Strategic buyers · 1
Tier 1 · Very High · score 70+
19. Gilead Sciences CorporateVery High77
6 acquisitions in Healthcare · 4 deals 2024–26
Accelerating: 4 deals in the last 2 years vs 0.3/yr before.
Bought Tubulis from Athos, 2026 · Biotech, Germany
Scores and facts derive from verified deal records only; sample floors and thresholds are published on the methodology page. Figures marked with a tilde are bands, not disclosures.